Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 12001-12050 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04769037
Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity
NAActive, not recruiting
1,149 participants
Started: Apr 22, 2021 · Completed: Oct 31, 2027
1 condition9 sponsors8 locations
NCT04797247
Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reduction
PHASE3Active, not recruiting
900 participants
Started: Apr 22, 2021 · Completed: Feb 28, 2024
2 conditions2 sponsors3 locations
NCT04309565
Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support
NAActive, not recruiting
400 participants
Started: Apr 21, 2021 · Completed: Dec 30, 2025
1 condition10 sponsors5 locations
NCT05496972
Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology
N/AActive, not recruiting
200 participants
Started: Apr 21, 2021 · Completed: Jul 1, 2027
2 conditions1 sponsor1 location
NCT05678426
TirolGESUND: Baseline-controlled Comparison of the Effects of Fasting Dietary Intervention or Smoking Cessation Combined With Exercise in Healthy Female Tyrolean Volunteers Aged 30-60 on Epigenetic and Multi-omic Biomarkers of Health, Ageing, and Disease
NAActive, not recruiting
156 participants
Started: Apr 21, 2021 · Completed: Dec 31, 2024
4 conditions2 sponsors1 location
NCT04633369
The Role of the Microbiome in the Response to Dietary Fibers Intake During Intermediate Fasting
NAActive, not recruiting
115 participants
Started: Apr 21, 2021 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT04700124
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
PHASE3Active, not recruiting
808 participants
Started: Apr 21, 2021 · Completed: Dec 23, 2026
1 condition3 sponsors188 locations
NCT04656535
AB154 Combined With AB122 for Recurrent Glioblastoma
EARLY_PHASE1Active, not recruiting
46 participants
Started: Apr 21, 2021 · Completed: Dec 31, 2025
1 condition3 sponsors3 locations
NCT04874558
Ultra-low-dose Chest CT for HHT
N/AActive, not recruiting
10 participants
Started: Apr 21, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05057559
Observational Clinical Investigation of Arthrosamid in Knee Osteoarthritis
N/AActive, not recruiting
201 participants
Started: Apr 21, 2021 · Completed: Jul 1, 2028
1 condition1 sponsor9 locations
NCT04725396
Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPC
NAActive, not recruiting
132 participants
Started: Apr 20, 2021 · Completed: Sep 30, 2025
2 conditions1 sponsor10 locations
NCT04872985
Pyrotinib Plus Neoadjuvant Chemotherapy in HR+/HER2-, HER4-High Breast Cancer
PHASE2Active, not recruiting
140 participants
Started: Apr 20, 2021 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT06378294
Locoregional Control With Radiotherapy of Breast Cancer Patients With MACrometastases Treated With MAstectomy (MACMA)
N/AActive, not recruiting
82 participants
Started: Apr 20, 2021 · Completed: Dec 31, 2029
1 condition7 sponsors7 locations
NCT04854005
Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation
N/AActive, not recruiting
78 participants
Started: Apr 20, 2021 · Completed: Apr 30, 2026
1 condition1 sponsor10 locations
NCT04820387
Assessment of Remote Vital Signs for Telemedicine Applications
N/AActive, not recruiting
94 participants
Started: Apr 20, 2021 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT04367675
INO 5401 Vaccination in BRCA1/2 Mutation Carriers
PHASE1Active, not recruiting
44 participants
Started: Apr 20, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04645706
Innate T Cells and TKI Discontinuation
N/AActive, not recruiting
92 participants
Started: Apr 20, 2021 · Completed: Apr 30, 2028
1 condition1 sponsor1 location
NCT04868838
Daratumumab to Treat Active Lupus Nephritis
PHASE2Active, not recruiting
12 participants
Started: Apr 20, 2021 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT04852289
A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans
N/AActive, not recruiting
78 participants
Started: Apr 20, 2021 · Completed: Jun 30, 2027
1 condition1 sponsor2 locations
NCT04649489
A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer with PVTT, HVTT or IVCTT After Initial Ate/Bev
N/AActive, not recruiting
501 participants
Started: Apr 19, 2021 · Completed: Mar 31, 2028
1 condition1 sponsor23 locations
NCT04729907
A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD)
PHASE3Active, not recruiting
115 participants
Started: Apr 19, 2021 · Completed: Jul 31, 2026
1 condition1 sponsor39 locations
NCT06286956
Rectal Tumor Resection Using the UNI-VEC Multichannel Transanal Access Device
NAActive, not recruiting
40 participants
Started: Apr 19, 2021 · Completed: May 7, 2025
5 conditions1 sponsor11 locations
NCT04863495
Couples Lived Experience
N/AActive, not recruiting
600 participants
Started: Apr 19, 2021 · Completed: Aug 1, 2026
2 conditions2 sponsors2 locations
NCT04758533
Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy
PHASE1/PHASE2Active, not recruiting
13 participants
Started: Apr 19, 2021 · Completed: Apr 30, 2026
2 conditions2 sponsors1 location
NCT04589650
Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum
PHASE2Active, not recruiting
205 participants
Started: Apr 19, 2021 · Completed: Feb 28, 2031
1 condition1 sponsor36 locations
NCT04844619
KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial
PHASE1Active, not recruiting
40 participants
Started: Apr 19, 2021 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT04526613
The Influence of Malnutrition, Diabetes Mellitus, and Helminth Infections on Biosignatures in Latent Tuberculosis in a South Indian Population
N/AActive, not recruiting
626 participants
Started: Apr 19, 2021 · Completed: Jun 25, 2026
5 conditions1 sponsor1 location
NCT04625647
Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
PHASE2Active, not recruiting
116 participants
Started: Apr 16, 2021 · Completed: Dec 31, 2027
6 conditions2 sponsors713 locations
NCT04770805
In Utero Fetoscopic Repair Program for Sacral Myelomeningoceles and Mye-LDM
NAActive, not recruiting
10 participants
Started: Apr 16, 2021 · Completed: Dec 8, 2025
3 conditions1 sponsor1 location
NCT04604197
ANGiographic Evaluation of Left Main Coronary Artery INtErvention
NAActive, not recruiting
400 participants
Started: Apr 16, 2021 · Completed: Dec 1, 2025
5 conditions1 sponsor30 locations
NCT04275999
Rosacea and Ivermectin
PHASE2Active, not recruiting
30 participants
Started: Apr 16, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04730258
A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML
PHASE1/PHASE2Active, not recruiting
72 participants
Started: Apr 16, 2021 · Completed: Jan 31, 2026
6 conditions1 sponsor9 locations
NCT04680052
A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.
PHASE3Active, not recruiting
654 participants
Started: Apr 15, 2021 · Completed: Aug 9, 2028
2 conditions1 sponsor261 locations
NCT04950153
Intensive Combination Approach to Rollback the Epidemic in Nigerian Adolescents: UH3 Phase
NAActive, not recruiting
558 participants
Started: Apr 15, 2021 · Completed: Dec 31, 2024
1 condition2 sponsors6 locations
NCT04953637
Physiotherapy and Deep Brain Stimulation in Parkinson's Disease
NAActive, not recruiting
60 participants
Started: Apr 15, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04697940
Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL
PHASE1/PHASE2Active, not recruiting
33 participants
Started: Apr 15, 2021 · Completed: Sep 1, 2026
2 conditions1 sponsor1 location
NCT04742400
Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
PHASE2Active, not recruiting
12 participants
Started: Apr 15, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04772521
Smoking Cessation Programme in Workplaces in Hong Kong (Phase Ⅴ)
NAActive, not recruiting
300 participants
Started: Apr 15, 2021 · Completed: Dec 30, 2023
1 condition2 sponsors1 location
NCT04534972
Strategy to Avoid Excessive Oxygen in Major Burn Patients
PHASE3Active, not recruiting
2,000 participants
Started: Apr 15, 2021 · Completed: Dec 31, 2025
4 conditions2 sponsors6 locations
NCT04965259
Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)
N/AActive, not recruiting
2,002 participants
Started: Apr 15, 2021 · Completed: Dec 21, 2026
1 condition7 sponsors14 locations
NCT04672265
Increasing Access to Breast Cancer Screening Among Immigrants
NAActive, not recruiting
11,355 participants
Started: Apr 15, 2021 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT04270175
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
PHASE2Active, not recruiting
15 participants
Started: Apr 14, 2021 · Completed: Sep 30, 2027
3 conditions2 sponsors4 locations
NCT04875351
Breast Cancer Index (BCI) Registry
N/AActive, not recruiting
3,465 participants
Started: Apr 14, 2021 · Completed: Dec 31, 2028
1 condition1 sponsor105 locations
NCT04736706
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
PHASE3Active, not recruiting
1,653 participants
Started: Apr 14, 2021 · Completed: Oct 29, 2026
1 condition2 sponsors262 locations
NCT04514250
Stress Aortic Valve Index for Assessing Risk in Aortic Valve Stenosis Patients
N/AActive, not recruiting
52 participants
Started: Apr 14, 2021 · Completed: Oct 1, 2028
1 condition1 sponsor5 locations
NCT04795635
Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain Compared to Conventional Medical Management
NAActive, not recruiting
61 participants
Started: Apr 14, 2021 · Completed: Aug 22, 2024
2 conditions1 sponsor3 locations
NCT04843904
Safe Accelerated Venetoclax Escalation in CLL
PHASE1Active, not recruiting
40 participants
Started: Apr 14, 2021 · Completed: Jun 2, 2030
2 conditions1 sponsor1 location
NCT04216316
Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer
PHASE1/PHASE2Active, not recruiting
12 participants
Started: Apr 14, 2021 · Completed: Apr 12, 2025
2 conditions1 sponsor34 locations
NCT04382963
Stroke Prevention in the Wisconsin Native American Population
NAActive, not recruiting
120 participants
Started: Apr 14, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT04763200
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function
NAActive, not recruiting
1,252 participants
Started: Apr 13, 2021 · Completed: Oct 31, 2027
2 conditions1 sponsor102 locations